Peptide Lab HQ Research Guide
Testagen
A research-focused compound profile covering Testagen identity, KEDG tetrapeptide research, peptide bioregulator models, reproductive endocrine research context, concentration reference, preparation reference, and safety considerations.
Compound Data
Compound Profile
| Compound Name | Testagen |
|---|---|
| Common Research Name | KEDG tetrapeptide |
| Common Synonyms | Lys-Glu-Asp-Gly, H-Lys-Glu-Asp-Gly-OH, KEDG peptide, anterior pituitary peptide, testicular bioregulator peptide |
| Compound Type | Synthetic ultrashort tetrapeptide / peptide bioregulator research compound |
| CAS Number | Commonly listed as 1026993-38-3; verify against supplier COA |
| Amino Acid Length | 4 amino acids |
| Amino Acid Sequence | Lys-Glu-Asp-Gly |
| Short Sequence | KEDG |
| Molecular Formula | C₁₇H₂₉N₅O₉; verify against supplier COA |
| Molecular Weight | Approximately 447.44 g/mol; verify against supplier COA |
| Research Category | Peptide bioregulator, reproductive endocrine model, testicular tissue context, anterior pituitary context, gene-expression, histone/DNA interaction, and aging-marker research |
| Research Context | Commonly discussed in ultrashort peptide bioregulator research involving endocrine signaling, reproductive tissue models, gene-expression patterns, and short-peptide interaction with histone/DNA complexes. |
| Appearance | White to off-white lyophilized powder, depending on supplier documentation |
| Use | For laboratory research use only. |
Research Applications
Key Research Applications
Testagen is commonly discussed in controlled research models involving KEDG tetrapeptide activity, peptide bioregulation, reproductive endocrine signaling, testicular tissue context, anterior pituitary pathway context, histone/DNA interaction models, and gene-expression regulation.
Peptide Bioregulator Research
Testagen is commonly positioned within ultrashort peptide bioregulator research, where short amino acid sequences are studied for tissue-specific signaling and gene-expression related effects.
Reproductive Endocrine Models
Testagen is commonly discussed in research involving testicular tissue context, testosterone-biosynthesis pathway markers, and reproductive endocrine signaling models.
Anterior Pituitary Context
Some public references describe Testagen as an anterior-pituitary peptide research compound, making it relevant to pituitary-gonadal signaling models.
Histone / DNA Interaction Research
Testagen is discussed in short-peptide research involving histone proteins, DNA complexes, and potential transcriptional-response mechanisms.
Gene-Expression Context
KEDG-related research is often framed around gene-expression activity, protein synthesis, transcriptional regulation, and tissue-specific signaling models.
Aging-Marker Research
Short peptide bioregulator research commonly evaluates age-associated endocrine markers, cellular renewal patterns, and tissue-response documentation.
Research Scope
These applications are provided for educational and research-reference purposes only. Testagen research is limited compared with major peptide categories, and outcomes may vary based on sequence identity, purity, study model, concentration, exposure duration, tissue model, and laboratory conditions.
Reference Only
Reconstitution / Research Dosing Reference
Quick Reference Summary
| Reference Vial | 20 mg Testagen |
|---|---|
| Primary Solution Volume | 1.0 mL bacteriostatic water |
| Primary Concentration | 20 mg/mL |
| Measurement Reference | On a U-100 syringe, 1 unit = 0.01 mL. |
| Amount per U-100 Unit | At 20 mg/mL, 1 unit equals 0.2 mg / 200 mcg Testagen. |
| Storage Reference | Refrigerate at 2–8°C / 35.6–46.4°F after reconstitution, protected from direct light. |
Reconstitution Steps
- Draw 1.0 mL bacteriostatic water using a sterile syringe for the main concentration reference shown below.
- Slowly add the BAC water down the side of the vial wall.
- Gently roll or swirl the vial until the material is completely dissolved. The solution should appear clear to slightly hazy depending on concentration and supplier format. Do not shake!
- Because this is a concentrated 20 mg/mL preparation, verify complete dissolution before recording final preparation details.
- Label with compound name, vial amount, concentration, solvent volume, preparation date, storage conditions, and handling notes.
- Store refrigerated at 2–8°C / 35.6–46.4°F, protected from direct light.
Published Research Context
| Reference Type | Reported Amount / Context | Research Notes |
|---|---|---|
| Compound Identity Reference | Testagen, commonly referenced as KEDG / Lys-Glu-Asp-Gly | Testagen is commonly discussed as a synthetic tetrapeptide bioregulator in endocrine, pituitary-axis, testicular-tissue, and tissue-specific regulatory research contexts. |
| Peptide Bioregulator Research | Model-dependent concentration and endpoint tracking | Commonly discussed in short-peptide bioregulator, DNA / histone interaction, chromatin-organization, gene-expression, cellular-response, and regulatory peptide research contexts. |
| Endocrine / HPG-Axis Research Context | Experimental and model-dependent context | Testagen is often discussed in hypothalamic-pituitary-gonadal axis, pituitary signaling, testicular-tissue response, Leydig-cell marker, Sertoli-cell marker, and steroidogenesis-marker research contexts. |
| Thyroid / Pituitary Research Context | Model-dependent endocrine-marker context | Public research discussions commonly include pituitary-thyroid axis, TSH marker, T3 / T4 marker, endocrine-response, and hormone-regulation model references. |
| Gene-Expression Research Context | Short peptide / DNA interaction context | Short peptide bioregulator literature commonly discusses DNA interaction, regulatory sequence context, chromatin structure, and changes in gene-expression marker patterns depending on the model. |
| Public Protocol-Style Reference | Milligram-range reference examples | Public protocol-style references commonly describe Testagen in milligram-range examples. These are not clinical dosing standards. |
| Clinical / Research-Chemical Status | No universal research-chemical protocol established | Published study references, public protocol-style references, clinical-use references, or wellness protocols should not be treated as dosing instructions for research-chemical vial formats. |
Concentration Reference
| Vial Amount | Solution Volume | Final Concentration |
|---|---|---|
| 20 mg | 1.0 mL | 20 mg/mL |
Research Dosing Amount / Volume Reference
| Reference Amount | Volume at 20 mg/mL | U-100 Unit Reference | Approx. References per 20 mg Vial |
|---|---|---|---|
| 0.5 mg / 500 mcg | 0.025 mL | 2.5 units | 40 |
| 1 mg / 1000 mcg | 0.05 mL | 5 units | 20 |
| 2 mg / 2000 mcg | 0.10 mL | 10 units | 10 |
| 5 mg / 5000 mcg | 0.25 mL | 25 units | 4 |
| 10 mg / 10000 mcg | 0.50 mL | 50 units | 2 |
| 20 mg / 20000 mcg | 1.00 mL | 100 units | 1 |
Research Frequency / Amount Reference
| Research Window | Frequency | Reference Amount | Units / Volume Reference |
|---|---|---|---|
| Lower Conversion Reference | Public protocol-style reference, not a clinical dosing standard | 0.5 mg reference amount | 2.5 units / 0.025 mL |
| Standard Conversion Reference | Public protocol-style reference, not a clinical dosing standard | 1 mg reference amount | 5 units / 0.05 mL |
| Mid-Range Conversion Example | Calculation reference only | 2 mg reference amount | 10 units / 0.10 mL |
| Upper Conversion Example | Calculation reference only | 5 mg reference amount | 25 units / 0.25 mL |
| High Conversion Example | Calculation reference only | 10 mg reference amount | 50 units / 0.50 mL |
| Full-Vial Preparation Reference | Preparation-level calculation reference | 20 mg reference amount | 100 units / 1.00 mL |
Common Research Windows
| Reference Window | Common Length | Research Notes |
|---|---|---|
| Cell-Culture / Gene-Expression Window | 24–72 hours | May be used for gene-expression, DNA / histone interaction, chromatin-organization, cellular-response, endocrine-marker, or peptide-response documentation depending on the model. |
| Acute Endocrine Observation Window | Single session to several days | Used for early response tracking, endocrine-marker comparison, pituitary-axis observation, or short-term pathway documentation depending on the research design. |
| Short Research Window | 1–2 weeks | May be used for short-duration controlled observation involving endocrine-axis, HPG-axis, thyroid-axis, testicular-tissue, or gene-expression endpoints. |
| Standard Protocol-Style Window | 2–4 weeks | Commonly used in public protocol-style references for structured observation and comparison across baseline and follow-up periods. |
| Extended Observation Window | 4–8 weeks | Used when longer documentation is needed for endocrine-marker trends, tissue-specific marker response, cellular-aging context, or follow-up marker tracking. |
| Follow-Up / Washout | 1–4 weeks | Used to document post-study observations, marker return, delayed response patterns, or follow-up data depending on the research model. |
Research Note: These tables are provided for educational, research-planning, concentration, frequency-reference, and volume-reference purposes only. Testagen, commonly referenced as KEDG / Lys-Glu-Asp-Gly, is discussed in peptide bioregulator, endocrine-axis, pituitary-axis, testicular-tissue, thyroid-axis, DNA / histone interaction, chromatin-organization, gene-expression, and tissue-specific regulatory research contexts. This reference uses a 20 mg vial reconstituted with 1.0 mL bacteriostatic water, creating a 20 mg/mL concentration. Higher-concentration preparations may require supplier-specific handling, solvent-volume, or solubility notes; verify against the COA, batch record, or formula record when available. Published study references and public protocol-style frequency references are not universal research-chemical dosing standards and should not be treated as dosing instructions for research-chemical vial formats. This information is not medical advice, dosing instruction, injectable-use guidance, or a recommendation for human or animal use.
Research Notes
Research Findings & Safety Notes
Research Findings
Testagen is commonly discussed in research involving ultrashort peptide bioregulation, KEDG tetrapeptide signaling, reproductive endocrine models, pituitary-gonadal axis context, histone/DNA interaction, gene-expression regulation, and aging-associated endocrine markers.
Study Limitations
Testagen research is limited compared with major peptide categories and includes peptide bioregulator, reproductive endocrine, pituitary-gonadal, and gene-expression research references. Findings should be interpreted according to peptide sequence, purity, model type, concentration, exposure duration, and endpoint selection.
Safety Considerations
Research discussion should account for peptide identity verification, KEDG sequence confirmation, endocrine-pathway context, sterility documentation, endotoxin risk, supplier qualification, batch records, storage conditions, and qualified laboratory handling procedures.
Use Restriction
Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease when discussed as a research-use material.
Related Supplies
Research Supplies
For research supplies, visit our affiliate partner and use code PLHQ10 to save 10% on your order.
Bacteriostatic Water
Commonly referenced in laboratory preparation workflows.
Research Syringes
Supply category for controlled laboratory research preparation.
Prep Supplies
Supporting supplies for clean handling, preparation, and documentation.
Lab Handling
Handling & Storage
Storage
Store materials according to product-specific requirements. Protect from excessive heat, moisture, and direct light.
After Reconstitution
Keep refrigerated after reconstitution unless otherwise specified by the product documentation.
Handling
Use appropriate laboratory PPE, clean handling practices, and qualified research procedures.
Documentation
Maintain batch details, COA records, preparation notes, and internal research documentation.